Topics

Human medicines European public assessment report (EPAR): Valdoxan, Agomelatine, Depressive Disorder, Major, Date of authorisation: 19/02/2009, Revision: 20, Status: Authorised

10:34 EDT 12 Jul 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Valdoxan, Agomelatine, Depressive Disorder, Major, Date of authorisation: 19/02/2009, Revision: 20, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Valdoxan, Agomelatine, Depressive Disorder, Major, Date of authorisation: 19/02/2009, Revision: 20, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Valdoxan, Agomelatine, Depressive Disorder, Major, Date of authorisation: 19/02/2009, Revision: 20, Status: Authorised"

Quick Search